Literature DB >> 3028046

Tumours of the central nervous system. Proton magnetic resonance relaxation times T1 and T2 and histopathologic correlates.

E Englund, A Brun, E M Larsson, Z Györffy-Wagner, B Persson.   

Abstract

Proton MR relaxation times T1 and T2 were determined in vitro in 136 small specimens of astrocytomas grades I-IV, of oligodendrogliomas, metastases of adenocarcinomas, meningiomas and acoustic neuromas. In addition, 7 samples of peritumoural white matter were analysed. The analysed specimens were studied microscopically in their entirety regarding tumour type and occurrence of necrosis and non-tumour tissue admixture, such as fibrosis and haemorrhage. Most of the gliomas had longer relaxation times than normal white matter and T2 was significantly longer than in the other three tumour groups. The metastases had longer T1 than normal white matter, while T2 varied. The astrocytomas tended to show shorter relaxation times with increasing degree of malignancy, and shortening of T1 and T2 correlating with the proportion of tissue necrosis. Similarly, the metastases with tissue necrosis had shorter T1 and T2 than non-necrotic samples. The meningiomas had T1 values comparable with normal cortex, while the T2 values varied. Tumours containing a large proportion of fibrous tissue had shorter relaxation times than the others. Acoustic neuromas had only slightly longer T1 than normal white matter, while T2 was not prolonged. Both T1 and T2 were significantly shorter than in all other tumours studied. Peritumoural white matter had prolonged relaxation times compared with normal white matter, correlating to increased water content. These in vitro differences regarding relaxation times in various types of tumours of the central nervous system, dependent on various types of tissue alterations, should be of interest for the interpretation of in vivo images.

Entities:  

Mesh:

Year:  1986        PMID: 3028046     DOI: 10.1177/028418518602700606

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  9 in total

Review 1.  MR imaging of cerebral tumors: state of the art and work in progress.

Authors:  H P Higer; P Pedrosa; M Schuth
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

2.  Evaluation of MRI score in the differentiation between glioblastoma multiforme and metastatic adenocarcinoma of the brain.

Authors:  S Asari; T Makabe; S Katayama; T Itoh; S Tsuchida; K Kunishio; T Ohmoto
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  Correlation of relaxometry and histopathology: the transplantable human glioblastoma SF295 grown in athymic nude mice.

Authors:  M Spiller; P C Merker; M J Iatropoulos; S M Childress; G M Williams; S S Kasoff
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Characterization of brain tumours with spin-spin relaxation: pilot case study reveals unique T 2 distribution profiles of glioblastoma, oligodendroglioma and meningioma.

Authors:  Cornelia Laule; Thorarin A Bjarnason; Irene M Vavasour; Anthony L Traboulsee; G R Wayne Moore; David K B Li; Alex L MacKay
Journal:  J Neurol       Date:  2017-09-11       Impact factor: 4.849

5.  Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.

Authors:  Stephanie Lescher; Alina Jurcoane; Andreas Veit; Oliver Bähr; Ralf Deichmann; Elke Hattingen
Journal:  Neuroradiology       Date:  2014-10-07       Impact factor: 2.804

6.  Assessment of the pathological grade of astrocytic gliomas using an MRI score.

Authors:  S Asari; T Makabe; S Katayama; T Itoh; S Tsuchida; T Ohmoto
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

7.  Variation of the magnetic relaxation rate 1/T1 of water protons with magnetic field strength (NMRD profile) of untreated, non-calcified, human astrocytomas: correlation with histology and solids content.

Authors:  M Spiller; S S Kasoff; T A Lansen; S Rifkinson-Mann; M P Valsamis; S H Koenig; M S Tenner
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.

Authors:  Thomas C Booth; Evita C Wiegers; Esther A H Warnert; Kathleen M Schmainda; Frank Riemer; Ruben E Nechifor; Vera C Keil; Gilbert Hangel; Patrícia Figueiredo; Maria Del Mar Álvarez-Torres; Otto M Henriksen
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 5.738

9.  Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients.

Authors:  Elke Hattingen; Andreas Müller; Martin Glas; Sied Kebir; Alina Jurcoane; Burkhard Mädler; Philip Ditter; Hans Schild; Ulrich Herrlinger
Journal:  Oncotarget       Date:  2017-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.